Life Sciences

The-Bellwether-District-Philadelphia

By Andrew Chused, founding partner, head of investments, Hilco Redevelopment Partners From the nation’s beginning to modern times, Philadelphia has been a bellwether city with a proud legacy of leading the nation to many of its firsts, including the country’s inaugural medical school, library, hospital, business school and stock exchange. In this city of firsts, Hilco Redevelopment Partners (HRP) is unlocking and reinventing a large portion of the city: the former 1,300-acre Philadelphia Energy Solutions (PES) site on the city’s southwest side. Not only is the redevelopment of this site transforming a relic of the city’s industrial age into a new, sustainable economy for the first time, but the project will also transform the way logistics and life sciences companies grow in southwest Philadelphia. An Economic Hub The site, aptly named The Bellwether District, represents a new ecosystem for a variety of tenants, including logistics, e-commerce and life sciences. Located in the shadows of University City and along the Schuylkill River, the project will create over 32,000 jobs and serve as an economic catalyst that drives growth to the city and region for generations to come. Upon its acquisition of the property in June of 2020, HRP quickly began the …

FacebookTwitterLinkedinEmail

DURHAM, N.C. — A joint fund managed by Goldman Sachs Asset Management and Lincoln Harris is acquiring TBC, a 445,000-square-foot life sciences property located on Stirrup Creek Drive in Durham. Previously owned in part by Lincoln Harris, the campus is part of the Triangle Business Center and adjacent to Research Triangle Park. Tenants at the property, which comprises five single-story buildings, include DuPont, Carsgen Therapeutics, Brightview Technologies, HemoSonics and Charles River Labs. The campus also includes a newly completed, 14,000-square-foot amenity center featuring a fitness center, outdoor recreational space, shower facilities and lounge and conference space. The seller and terms of the transaction were not disclosed.

FacebookTwitterLinkedinEmail

COLLEGE STATION, TEXAS — Oldham Goodwin has sold the Westinghouse Building at Providence Park, a 175,752-square-foot life sciences facility in College Station. Oldham Goodwin acquired the facility, which was originally built in 1983 as a manufacturing plant for Westinghouse Electronic Systems Group, in 2016. At that point, the facility had been shuttered since 1999. Dallas-based Big Sky Medical Real Estate purchased the asset for an undisclosed price.

FacebookTwitterLinkedinEmail
Burlington-BioCenter

BURLINGTON, MASS. — MetLife Investment Management has acquired Burlington BioCenter, a 109,085-square-foot life sciences facility located about 15 miles northwest of Boston, for $103 million. The facility was converted to life sciences from office usage in 2019 and was fully leased at the time of sale. Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented the seller, a partnership between The Gutierrez Co. and GEM Realty Capital, in the transaction. David Douvadjian Sr. and Timothy O’Donnell, also with Newmark, arranged an undisclosed amount of acquisition financing on behalf of the buyer.

FacebookTwitterLinkedinEmail
Dicerna-Pharmaceuticals-Lexington-Massachusetts

LEXINGTON, MASS. — Locally based biotechnology firm Dicerna Pharmaceuticals has signed a 107,238-square-foot life sciences lease expansion at its Hayden Avenue Campus in Lexington, located north of Boston. The tenant, which has operated out of the site since 2014, currently occupies more than 90,000 square feet. The expansion brings Dicerna’s total footprint in Lexington to more than 275,000 square feet. Boston-based King Street Properties owns the Hayden Avenue Campus.

FacebookTwitterLinkedinEmail
7000-Shoreline-Ct-South-San-Francisco-CA

SOUTH SAN FRANCISCO AND SAN CARLOS, CALIF. — JLL Capital Markets has arranged $213.4 million in financing for a five-building life sciences portfolio in South San Francisco and San Carlos. The borrower is an affiliate of GI Partners. Kevin MacKenzie, Brian Torp, Alex Witt and Samuel Godfrey of the JLL Capital Markets Debt Advisory team secured the seven-year, fixed-rate loan through a life insurance company. Loan proceeds were used to finance the assets acquired via a recent Sale, which JLL also arranged. Totaling 325,977 square feet, the buildings are located at 7000 Shoreline Court and 341-343 Oyster Point Boulevard in South San Francisco and 75 and 125 Shoreway Road in San Carlos.

FacebookTwitterLinkedinEmail

PLAINSBORO, N.J. — Cushman & Wakefield has brokered the sale of a 44,400-square-foot life sciences facility located at 107 Morgan Lane in Plainsboro, a suburb of Princeton. At the time of sale, the single-story building was leased to a subsidiary of global pharmaceutical firm WuXi AppTec. Frank DiTommaso, David Bernhaut and Andy Merin of Cushman & Wakefield represented the seller, XBL Realty, in the transaction. The buyer was undisclosed.

FacebookTwitterLinkedinEmail
585-Kendall

CAMBRIDGE, MASS. — San Diego-based REIT BioMed Realty has broken ground on 585 Kendall, a 600,000-square-foot life sciences facility in the Kendall Square area of Cambridge that will be a build-to-suit for Japanese pharmaceutical giant Takeda. CBT Architects designed the facility, which will include a 30,000-square-foot performing arts center with a 400-seat theater that will be open to the public. Completion of the project is slated for 2026.

FacebookTwitterLinkedinEmail
Oxford Properties Group-Oxford Properties Expands its San Diego

CARLSBAD, CALIF. — Oxford Properties has expanded its life sciences portfolio in metro San Diego with the acquisition and long-term leaseback of Ionis Pharmaceuticals’ 18.4-acre life sciences campus and corporate headquarters in Carlsbad. As part of the transaction, Ionis will lease the properties for a minimum of 15 years. Additional terms of the transaction were not released. The three-building campus offers 250,000 square feet of existing office and life sciences space with chemistry labs, biology labs and R&D support systems, as well as a modern office space. The buildings were constructed between 2011 and 2021. Founded in 1989, Ionis is a publicly traded biotech company and a leader in discovering and developing RNA-targeted therapeutics.

FacebookTwitterLinkedinEmail
Riverside-Labs-Weston-Massachusetts

WESTON, MASS. — Newmark has arranged financing for Riverside Labs, a 340,000-square-foot life sciences project in Weston, a western suburb of Boston. Riverside Labs will comprise three buildings, the first of which is slated for a summer 2023 delivery. David Douvadjian Sr., Timothy O’Donnell, Brian Butler, David Douvadjian Jr. and Conor Reenstierna of Newmark arranged the debt through Royal Bank of Canada on behalf of the borrower, a partnership between Greatland Realty Partners and Rockwood Capital. The loan, the amount of which was not disclosed, is part of Royal Bank of Canada’s $150 million total commitment to the development.

FacebookTwitterLinkedinEmail